Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clanz Technologies, commercially known as Sensi.AI, is a digital health company focused on AI-enabled senior care and long-term care monitoring. The company provides an always-on audio-based care intelligence platform used by home care agencies and other elder-care providers to detect changes in physical, emotional, and cognitive well-being without relying on cameras or wearables. Its platform analyzes ambient audio and care-environment signals to identify events such as falls, medication issues, signs of urinary tract infection, social isolation, and potential caregiver maltreatment, and then surfaces actionable alerts and operational insights. Sensi.AI is positioned as a commercial care-intelligence platform for aging-in-place and long-term care, serving provider organizations across North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clanz Technologies.